The sale of Wells Fargo's $600mn-surplus US crop insurer is being conducted amid uncertainty over proposed reforms to the US multi-peril crop (MPCI) mechanism that could hit the profitability of the business.
The sale of Wells Fargo's $600mn-surplus US crop insurer is being conducted amid uncertainty over proposed reforms to the US multi-peril crop (MPCI) mechanism that could hit the profitability of the business.